Induction of anti‐β2‐glycoprotein I autoantibodies in mice by protein H of Streptococcus pyogenes |
| |
Authors: | G. M. A. VAN OS J. C. M. MEIJERS Ç. AGAR M. V. SERON J. A. MARQUART P. ÅKESSON R. T. URBANUS R. H. W. M. DERKSEN H. HERWALD M. MÖRGELIN P. G. DE GROOT |
| |
Affiliation: | 1. Department of Clinical Chemistry and Hematology, University Medical Center, CX, Utrecht;2. Departments of Experimental Vascular Medicine;3. Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands;4. Department of Clinical Sciences, Division of Infection Medicine, Lund University, Lund, Sweden;5. Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, CX, Utrecht, the Netherlands |
| |
Abstract: | Summary. Background: The antiphospholipid syndrome (APS) is characterized by the persistent presence of anti‐β2‐glycoprotein I (β2‐GPI) autoantibodies. β2‐GPI can exist in two conformations. In plasma it is a circular protein, whereas it adopts a fish‐hook conformation after binding to phospholipids. Only the latter conformation is recognized by patient antibodies. β2‐GPI has been shown to interact with Streptococcus pyogenes. Objective: To evaluate the potential of S. pyogenes‐derived proteins to induce anti‐β2‐GPI autoantibodies. Methods and results: Four S. pyogenes surface proteins (M1 protein, protein H, streptococcal collagen‐like protein A [SclA], and streptococcal collagen‐like protein B [SclB]) were found to interact with β2‐GPI. Only binding to protein H induces a conformational change in β2‐GPI, thereby exposing a cryptic epitope for APS‐related autoantibodies. Mice were injected with the four proteins. Only mice injected with protein H developed antibodies against the patient antibody‐related epitope in domain I of β2‐GPI. Patients with pharyngotonsillitis caused by S. pyogenes who developed anti‐protein H antibodies also generated anti‐β2‐GPI antibodies. Conclusions: Our study has demonstrated that a bacterial protein can induce a conformational change in β2‐GPI, resulting in the formation of antiβ2‐GPI autoantibodies. This constitutes a novel mechanism for the formation of anti‐β2‐GPI autoantibodies. |
| |
Keywords: | antiphospholipid syndrome autoantibodies β 2‐glycoprotein  I |
|
|